enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. GLP-1 Drugs Like Zepbound and Mounjaro May Help Reduce Sleep ...

   www.aol.com/glp-1-drugs-zepbound-moujaro...

   In clinical trials, GLP-1 drug tirzepatide reduced sleep apnea events by as much as two-thirds over the course of 52 weeks in patients with obstructive sleep apnea. Patients taking a placebo ...

3. Hypoglossal nerve stimulator - Wikipedia

   en.wikipedia.org/wiki/Hypoglossal_nerve_stimulator

   Certain patients with obstructive sleep apnea who are deemed eligible candidates may be offered the hypoglossal nerve stimulator as an alternative. FDA-approved hypoglossal nerve neurostimulation is considered medically reasonable and necessary for the treatment of moderate to severe obstructive sleep apnea when all of the following criteria are met: [4]

4. What is Sleep Apnea? Symptoms & Treatment Options - AOL

   www.aol.com/sleep-apnea-symptoms-treatment...

   Untreated sleep apnea can lead to serious health conditions. Moderate to severe sleep apnea can increase your risk of: High blood pressure. Heart failure. Cardiovascular disease. Stroke. Fatty ...

5. Vivos Therapeutics Schedules Release of Third Quarter 2024 ...

   lite.aol.com/tech/story/0022/20241113/9273434.htm

   Vivos’ management will conduct a conference call at 5:00 p.m. (Eastern Time) on November 14, 2024 to review the results and provide an overview of Vivos’ recent achievements and developments. To access Vivos’ investor conference call, please dial (800) 717-1738, or for international callers, (646) 307-1865.

6. Nasal EPAP - Wikipedia

   en.wikipedia.org/wiki/Nasal_EPAP

   Nasal expiratory positive airway pressure (Nasal EPAP) is a treatment for obstructive sleep apnea (OSA) and snoring. [1] [2]Contemporary EPAP devices have two small valves that allow air to be drawn in through each nostril, but not exhaled; the valves are held in place by adhesive tabs on the outside of the nose. [1]

7. Solriamfetol - Wikipedia

   en.wikipedia.org/wiki/Solriamfetol

   Solriamfetol is used to promote wakefulness in the treatment of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea in adults. [1] It appears to be more effective in improving excessive daytime sleepiness associated with obstructive sleep apnea than certain other wakefulness-promoting agents including modafinil, armodafinil, and pitolisant.